Abstract:Introduction: Pacemakers (PMs) are used to treat patients with severe bradycardia symptoms. They do, however, pose several complications. Even with these risks, there are only a few studies assessing PM implantation outcomes in resource-limited settings like Ethiopia and other sub-Saharan countries in general. Therefore, this study aims to assess the mid-term outcome of PM implantation in patients who have undergone PM implantation in the Cardiac Center of Ethiopia by identifying the rate and predictors of complications and death. Methodology: This retrospective study was conducted at the Cardiac Center of Ethiopia from October 2023 to January 2024 on patients who had PM implantation from September 2012 to August 2023 to assess the midterm outcome of the patients. Complication rate and all-cause mortality rate were the outcomes of our study. Multivariable logistic regression was used to identify factors associated with complications and death. To analyze survival times, a Kaplan-Meier analysis was performed. Results: This retrospective follow-up study included 182 patients who underwent PM implantation between September 2012 and August 2023 and were at least 18 years old. The patients' median follow-up duration was 72 months (Interquartile range (IQR): 36-96 months). At the end of the study, 26.4% of patients experienced complications. The three most frequent complications were lead dislodgement, which affected 6.6% of patients, PM-induced tachycardia, which affected 5.5% of patients, and early battery depletion, which affected 5.5% of patients. Older age (Adjusted Odds Ratio (AOR) 1.1, 95% CI 1.04-1.1, p value < 0.001), being female (AOR 4.5, 95%CI 2-9.9, p value < 0.001), having dual chamber PM (AOR 2.95, 95%CI 1.14-7.6, p value = 0.006) were predictors of complications. Thirty-one (17%) patients died during the follow-up period. The survival rates of our patients at 3, 5, and 10 years were 94.4%, 92.1%, and 65.5% respectively with a median survival time of 11 years. Patients with a higher Charlson comorbidity index before PM implantation (AOR 1.2, 95% CI 1.1-1.8, p = 0.04), presence of complications (AOR 3.5, 95% CI 1.2-10.6, p < 0.03), and New York Heart Association (NYHA) class III or IV (AOR 3.3, 95% CI 1.05-10.1, p = 0.04) were associated with mortality. Conclusion: Many complications were experienced by patients who had PMs implanted, and several factors affected their prognosis. Thus, it is essential to identify predictors of both complications and mortality to prioritize and address the manageable factors associated with both mortality and complications.

Eleven‐year Trends of Inpatient Pacemaker Implantation in Patients Diagnosed with Sick Sinus Syndrome

Abstract 12756: 11 Year Trends and Utilization Patterns of Cardiac Implantable Electronic Devices in Patients Diagnosed with Sick Sinus Syndrome

Cardiac Pacemaker Survey-Twenty Hospitals Pacemaker Implantation Registry in China

Trends in research on sick sinus syndrome: A bibliometric analysis from 2000 to 2022

Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation

Understanding disparities in cardiovascular death rates among older adults with sick sinus syndrome in the US

[Permanent Pacemaker Implantation for Sick Sinus Syndrome After Maze Procedure]

Predictors of complications and mortality among patients undergoing pacemaker implantation in resource-limited settings: a 10-year retrospective follow-up study

Contemporary trends of leadless pacemaker implantation in the United States

Pacing mode survival in patients with single chamber atrial pacemaker for sinus node dysfunction

Impact of COVID-19 infection among patients hospitalized for conventional pacemaker implantation: Analysis of the Nationwide Inpatient Sample (NIS) 2020

The Risk Factors of New-Onset Atrial Fibrillation after Pacemaker Implantation

Reduction of Unnecessary Right Ventricular Pacing by Managed Ventricular Pacing and Search AV+ Algorithms in Pacemaker Patients: 12-Month Follow-Up Results of a Randomized Study.

Predictors of pacemaker requirement in patients receiving implantable loop recorders for unexplained syncope: a systematic review and meta-analysis.

Clinical characteristics of patients undergoing cardioverter defibrillator implantation for primary and secondary prevention of sudden cardiac death

How Overall Health Status and Insurance Influence Utilization of the Primary Prevention Implantable Defibrillator in the Current Era

Comprehensive risk factor analysis for sick sinus syndrome: an analysis of genetic, sociodemographic, clinical and laboratory data from the UK Biobank

Stroke in paced patients with sick sinus syndrome: relevance of atrial mechanical function, pacing mode and clinical characteristics

Long-term follow-up of single-chamber atrial pacing - system upgrade and wenckebach block point behavior: potential implications for leadless AAI pacing?

Risk of Malignant Ventricular Arrhythmias in Patients with Mild to Moderately Reduced Ejection Fraction Following Permanent Pacemaker Implantation

The effect of unhealthy lifestyle on the pathogenesis of sick sinus syndrome: A life-guiding review